Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 20;11(10):e0066422.
doi: 10.1128/mra.00664-22. Epub 2022 Sep 21.

Complete Genome Sequence of Mycobacteriophage IgnatiusPatJac

Affiliations

Complete Genome Sequence of Mycobacteriophage IgnatiusPatJac

Olivia Jacobs et al. Microbiol Resour Announc. .

Abstract

IgnatiusPatJac is a Siphoviridae mycobacteriophage capable of lytic infection in Mycobacterium smegmatis and Mycobacterium tuberculosis. It was isolated from damp soil in Johannesburg, South Africa. The 51,164-bp double-stranded DNA genome has a GC content of 63.6%, predicted to encode 93 genes. IgnatiusPatJac is classified as an A1 subcluster mycobacteriophage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Genome organization of mycobacteriophage IgnatiusPatJac. The double-stranded DNA genome of IgnatiusPatJac is represented as a horizontal bar with vertical markers at every kilobase pair. Gene numbers are shown in boxes, which are shaded according to their phamily assignments determined using Phamerator (7). Boxes above and below represent transcription from plus and negative strands, respectively. Putative gene functions, based on BLAST analyses, are indicated. The inset represents a transmission electron micrograph of IgnatiusPatJac (scale bar equivalent to 50 nm). Droplets of purified IgnatiusPatJac lysate were placed onto copper grids (Agar Scientific, UK), coated with carbon, and rendered hydrophilic using an EMS100 Glow Discharge Unit (Electron Microscopy Sciences, USA). Samples were visualized using negative staining with 2% uranyl acetate (SPI Supplies, USA).

References

    1. WHO. 2021. Global tuberculosis report. WHO, Geneva, Switzerland.
    1. Onyebujoh P, Zumla A, Ribeiro I, Rustomjee R, Mwaba P, Gomes M, Grange JM. 2005. Treatment of tuberculosis: present status and future prospects. Bull World Health Organ 83:857–865. - PMC - PubMed
    1. Guerrero-Bustamante CA, Dedrick RM, Garlena RA, Russell DA, Hatfull GF. 2021. Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains. mBio 12:e00973-21. doi:10.1128/mBio.00973-21. - DOI - PMC - PubMed
    1. Azimi T, Mosadegh M, Nasiri MJ, Sabour S, Karimaei S, Nasser A. 2019. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infect Drug Resist 12:2943–2959. doi:10.2147/IDR.S218638. - DOI - PMC - PubMed
    1. Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S, Schooley RT. 2020. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis 7:ofaa389. doi:10.1093/ofid/ofaa389. - DOI - PMC - PubMed

LinkOut - more resources